ReviewBiomedicines2024

Immunological Mechanisms behind Anti-PD-1/PD-L1 Immune Checkpoint Blockade: Intratumoral Reinvigoration or Systemic Induction?

Zhikun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.